Navigation Links
Mylan Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Closing Bell
Date:7/29/2009

PITTSBURGH, July 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Chairman and CEO Robert J. Coury will preside over the NASDAQ Stock Market closing on Thursday, July 30 from 3:45 to 4:00 p.m. ET.

Feed Information: The Closing Bell is available from 3:50 p.m. to 4:05 p.m. on AMC-3/C-3 (ul 5985V; dl 3760H). The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at 646.441.5045.

Radio Feed: An audio transmission of the Closing Bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Webcast: A live webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a high-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Mylan Inc. [MYL]: Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industries broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please visit

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... OncLive® will team with ... as it further expands its Strategic Alliance Partnership Program for raising awareness of ... OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to share the ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted by ... 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will ... zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders from ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
(Date:7/1/2015)... ... 01, 2015 , ... Element Blue ™, a leading ... it has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is ... multiple sources providing an environment where users can view and compare real-time and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest ... purchasing two or more Bunion Booties directly from their website, http://www.BunionBootie.com ... corrects misaligned toes and its ultra thin properties allow for protection against rubbing ...
Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... Creates Explosive Growth for Domestic and, International ... Reach $5.974 Billion With ... ANGELES, May 20 With another sweltering summer,forecast for ... are,driving growth in the burgeoning, multi-billion dollar bottled water,industry ...
... wins multi-million dollar, multi-year technology ... Medical Center, Biloxi, MS, HOUSTON, May 20 Shipcom ... announced today,that they have been selected by the Air Force ... across the Air Force Medical,Service and then pilot RFID systems ...
... Patients the Ability to Share their Prescription History, ... Drug,Stores Corporation (NYSE: LDG ) announced today ... platform for sharing of information between,patients and providers. ... the first,pharmacies to provide their customers with the ...
... TX According to the 2000 census, Americans office ... at their desks or work stations. Many recent studies ... longer hours in office environments, often under artificial light ... stress levels. , How can employers make office environments ...
... May 19 Six years ago,Senator Patty Murray ... and invest federal funding in the research critically ... mesothelioma, and,other asbestos related diseases. Since 2002, the ... with Senator,Murray to stop the death and suffering ...
... Standard Therapy for Eradicating H. pylori , An ... and standard triple therapies in patients with documented, ... sequential therapy appears superior to standard triple therapy ... Authors say if further trials confirm these findings, ...
Cached Medicine News:Health News:H2O = Big Business in a Bottle 2Health News:H2O = Big Business in a Bottle 3Health News:H2O = Big Business in a Bottle 4Health News:H2O = Big Business in a Bottle 5Health News:H2O = Big Business in a Bottle 6Health News:H2O = Big Business in a Bottle 7Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 2Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 3Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 4Health News:Longs Drugs Partners With Google on the Launch of Google Health 2Health News:Greener offices make happier employees 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 3Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 4
(Date:7/1/2015)... , July 1, 2015 ExeGi Pharma, ... and probiotic treatments, announced today that it has been ... and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome™ ... Visbiome was developed by Professor Claudio De Simone ... extensive clinical investigation. Professor De Simone recently signed an ...
(Date:7/1/2015)... 2015 Boston Scientific Corporation (NYSE: BSX ) ... highlights for the second quarter ended June 30, 2015 on ... The call will be hosted by Mike Mahoney , ... executive vice president and chief financial officer. A ... the Boston Scientific website. Webcast registration is available on the ...
(Date:7/1/2015)... Fla. , July 1, 2015 Rock ... development company focused on chronic inflammatory disease and neurologic ... of principle study with anatabine citrate, the Company,s lead ... oral dose of anatabine citrate can significantly inhibit the ... subjects. The Company is developing this compound in a ...
Breaking Medicine Technology:ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... over a wide range of concentration, ... more thorough characterization than other methods. ... relative change in the distribution of ... to measure heterogeneity, stoichiometry and self-associating ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: